Mast Therapeutics Price Prediction

Macroaxis is not in business of monitoring Mast Therapeutics headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with Mast Therapeutics Inc brand which may create opportunities for some arbitrage if properly timed. With Mast Therapeutics hype-based prediction module you can estimate the value of Mast Therapeutics Inc from the prospective of Mast Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Mast Therapeutics over a specific investment horizon. Please see also Mast Therapeutics Basic Forecasting Models to cross-verify your projections.
Investment Horizon     30 Days    Login   to change

Mast Therapeutics estimiated after-hype price volatility

 Next price density 
Expected price to next headline
April 29, 2017
Current Value
Downside upside
After-hype Price
Target Price Odds
 Above  Below  
Upside upside
Mast Therapeutics is abnormally risky asset. Analysis and calculation of next after-hype price of Mast Therapeutics is based on 1 month time horizon.

Mast Therapeutics Hype Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.56% 5.51% 0.00%  0.08% 1 Events / Month1 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Mast Therapeutics Hype Timeline

Mast Therapeutics Inc is now traded for 0.13 . This company stock is not elastic to its hype. The average elasticity to hype of competition is 0.08. Mast Therapeutics Inc is projected to decline in value after the next headline with price expected to drop to 0.13. The average volatility of media hype impact on the company stock price is about 61910.11%. The price decrease on the next news is expected to be -0.76% where as daily expected return is now at 0.56%. The volatility of related hype on Mast Therapeutics is about 3756.82% with expected price after next announcement by competition of 0.21. About 23.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.91. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mast Therapeutics Inc recorded loss per share of 0.21. This company had not issued any dividends in recent years. The firm had 1:25 split on April 26, 2010. Given the investment horizon of 30 days, the next projected press release will be uncertain.
Please see also Mast Therapeutics Basic Forecasting Models to cross-verify your projections.

Mast Therapeutics Related Hype Analysis

Short fall
At Risk
Ionis Pharmaceuticals Inc 0.43 1 per month 1.42  0.38 (2.44)  4.72 (2.60)  9.34 
IntelliPharmaCeutics International Inc 0.08 1 per month 0.00 (0.27)  0.00  5.37 (5.77)  11.14 
Impax Laboratories Inc 0.40 1 per month 1.48  0.15 (2.94)  6.37 (2.62)  10.46 
NantKwest Inc(0.21) 1 per month 0.00 (0.16)  0.00  6.09 (5.11)  11.57 
King Pharmaceuticals Inc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00  0.00 
WuXi PharmaTech Inc 0.18 1 per month 0.00  0.34 (0.22)  0.42 (0.11)  0.60